Live feed08:00:00·739dPRReleasevia QuantisnowScience 37 Surpasses Enrollment Goals, Accelerates Phase 2 Rare Disease Clinical TrialByQuantisnow·Wall Street's wire, on your screen.SNCE· Science 37 Holdings Inc.Technology
